When SH-SY5Y neuroblastoma cells are treated with proteasome inhibitors in vitro, TTRAP forms aggresome-like structures in the cytoplasm and in the nucleolus where it participates in rRNA biogenesis [20], [23]. This evidence concerns the gene TDP2 and neuroblastoma.